Confluent Medical Technologies Expanding, Adding Capacity for Nitinol Processing and Catheter Manufacturing
Confluent Medical Technologies (Confluent), today announced a significant expansion of their Costa Rica manufacturing by adding a new facility to accommodate the increase in customer demand for specialized medical devices utilizing Nitinol components and complex catheters.
- Confluent Medical Technologies (Confluent), today announced a significant expansion of their Costa Rica manufacturing by adding a new facility to accommodate the increase in customer demand for specialized medical devices utilizing Nitinol components and complex catheters.
- The new site will greatly expand Confluents capacity to process Nitinol components, as well as produce complex catheters using a combination of clean rooms and white-space manufacturing.
- Confluent has been experiencing consistent and strong growth in recent years, says Confluent President & CEO, Dean Schauer.
- Confluent supports some of the fastest growing medical device markets such as interventional Neurovascular, Electrophysiology, Structural Heart and Peripheral Vascular.